Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
2005 3
2006 2
2007 3
2008 8
2009 3
2010 7
2011 9
2012 11
2013 8
2014 10
2015 10
2016 9
2017 13
2018 16
2019 15
2020 17
2021 17
2022 10
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 28775174

157 results

Results by year

Filters applied: . Clear all
Page 1
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas.
Schrader AMR, de Groen RAL, Willemze R, Jansen PM, Quint KD, van Wezel T, van Eijk R, Ruano D, Tensen CP, Hauben E, Woei-A-Jin FJSH, Busschots AM, van den Berg A, Diepstra A, Vermeer MH, Vermaat JSP. Schrader AMR, et al. Virchows Arch. 2022 Mar;480(3):667-675. doi: 10.1007/s00428-021-03265-5. Epub 2022 Jan 14. Virchows Arch. 2022. PMID: 35028710 Free PMC article.
Clinical impact of the cell-of-origin classification based on immunohistochemistry criteria and Lymph2Cx of diffuse large B-Cell lymphoma patients in a South-east Asian population: a single center experience and review of the literature.
Lee J, Hue SS, Ko SQ, Tan SY, Liu X, Girard LP, Chan EHL, De Mel S, Jeyasekharan A, Chee YL, Koh LP, Poon LM. Lee J, et al. Expert Rev Hematol. 2019 Dec;12(12):1095-1105. doi: 10.1080/17474086.2019.1677152. Epub 2019 Oct 19. Expert Rev Hematol. 2019. PMID: 31592693 Review.
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
Staiger AM, Ziepert M, Horn H, Scott DW, Barth TFE, Bernd HW, Feller AC, Klapper W, Szczepanowski M, Hummel M, Stein H, Lenze D, Hansmann ML, Hartmann S, Möller P, Cogliatti S, Lenz G, Trümper L, Löffler M, Schmitz N, Pfreundschuh M, Rosenwald A, Ott G; German High-Grade Lymphoma Study Group. Staiger AM, et al. J Clin Oncol. 2017 Aug 1;35(22):2515-2526. doi: 10.1200/JCO.2016.70.3660. Epub 2017 May 19. J Clin Oncol. 2017. PMID: 28525305 Clinical Trial.
Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.
Abdulla M, Hollander P, Pandzic T, Mansouri L, Ednersson SB, Andersson PO, Hultdin M, Fors M, Erlanson M, Degerman S, Petersen HM, Asmar F, Grønbaek K, Enblad G, Cavelier L, Rosenquist R, Amini RM. Abdulla M, et al. Am J Hematol. 2020 Jan;95(1):57-67. doi: 10.1002/ajh.25666. Epub 2019 Nov 7. Am J Hematol. 2020. PMID: 31659781 Free PMC article.
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.
Scott DW, Mottok A, Ennishi D, Wright GW, Farinha P, Ben-Neriah S, Kridel R, Barry GS, Hother C, Abrisqueta P, Boyle M, Meissner B, Telenius A, Savage KJ, Sehn LH, Slack GW, Steidl C, Staudt LM, Connors JM, Rimsza LM, Gascoyne RD. Scott DW, et al. J Clin Oncol. 2015 Sep 10;33(26):2848-56. doi: 10.1200/JCO.2014.60.2383. Epub 2015 Aug 3. J Clin Oncol. 2015. PMID: 26240231 Free PMC article.
157 results